KRIBIOLISA™ Protein A ELISA
KRISHGEN BioSystemsImmunoassay for the measurement of Protein A in samples containing Human immunoglobulin.
Immunoassay for the measurement of Protein A in samples containing Human immunoglobulin.
Enzyme Immunoassay for the quantitative determination of PEG-GCSF in serum, plasma and cell culture supernatant.
Immunoassay for the measurement of Human Serum Albumin in cell culture samples.
Enzyme Immunoassay for the Qualitative / Quantitative Screening of double stranded RNA in mRNA based preparations.
Immunoassay for the measurement of E.coli Host Cell Proteins
ELISA for the detection of Blinatumomab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year
Enzyme Immunoassay for the Quantitative Determination of Faricimab in human serum and plasma.
Enzyme Immunoassay for the quantitative determination of Ocrelizumab in serum and plasma.
Enzyme Immunoassay for the quantitative determination of Pidilizumab in serum and plasma.
Enzyme Immunoassay for the Quantitative Determination of Relatlimab in human serum and plasma
Enzyme Immunoassay for the Quantitative Determination of Teclistamab in serum and plasma
Enzyme Immunoassay for the quantitative determination of Erenumab in serum and plasma.
Enzyme Immunoassay for the quantitative determination of Guselkumab in serum and plasma.
Enzyme Immunoassay for the Quantitative Determination of Cemiplimab in human serum and plasma
Enzyme Immunoassay for the Quantitative Determination of Amivantamab in serum and plasma
Canakinumab (ILARIS) ELISA for quantitative determination of Canakinumab (ILARIS) in human serum
Enzyme Immunoassay for the Quantitative Determination of Teprotumumab in serum and plasma.
ELISA for the detection of Mosunetuzumab in human serum and plasma.
Enzyme Immunoassay for the Quantitative Determination of Darbepoetin in human serum and plasma
Enzyme Immunoassay for the quantitative determination of Nilotinib in serum, plasma and cell culture supernatant
Enzyme Immunoassay for the Quantitative Determination of Dasatinib in human serum and plasma
Enzyme Immunoassay for the quantitative determination of Golimumab in serum, plasma and cell culture supernatant
Enzyme Immunoassay for the quantitative determination of Necitumumab in serum and plasma.
Immunoassay for quantitative estimation of Cafilzomib in human serum and plasma.